Relevate Health Group announces strategic combination with Arteric to form a new Data & Machine Learning driven Agency

CINCINNATI - Dec. 21, 2020 - PRLog -- Relevate Health Group, a data-driven marketing products and services communications firm, today announced the completion of a strategic combination with Arteric, a digital marketing agency known for its proprietary machine learning driven multichannel digital marketing.  This strategic combination forms a next generation data & ML-driven agency serving the pharmaceutical, biotechnology and healthcare markets.

Relevate received a strategic investment from middle market private equity firm, Mountaingate Capital to facilitate the transaction with Arteric, fund future growth and enable additional acquisitions.

Relevate, led by CEO Jeff Spanbauer and President Scott Weintraub, leverages a proprietary data analytics approach with scalable, locally focused products to create brand awareness and drive behavioral changes among healthcare providers (HCPs) and patients, for a consistently superior return on investment.  Headquartered in Cincinnati, Relevate has worked with 19 of the top 20 pharmaceutical and biotechnology manufacturers, as well as leading healthcare systems and eye-care companies.

Arteric, led by CEO Hans Kaspersetz, is a "digital native" agency providing ML-based digital programs and campaign execution tools.  Arteric, based in Summit, New Jersey, realized exceptional growth supporting five major US & global product launches in 2020.

The combined company will capitalize on its shared expertise to provide a full range of digital marketing services for leading, challenger and new growth brands. Clients can launch brands nationally, engage and monitor HCPs locally, and optimize marketing continuously via powerful analytics supporting multichannel targeting and execution across all digital channels.

"Relevate now offers even more powerful options for clients to reach HCPs and patients with new products and services, better addressing the sales and marketing challenges accelerated by COVID-19," said Mr. Spanbauer who will serve as CEO and Board member.

"Arteric has always been focused on innovative approaches using data, content, software and digital media to enable our clients to achieve dramatically better results in pre-launch, launch and post-launch campaigns.  With Relevate we have taken that vision to the next level," said Mr. Kaspersetz who will assume the role of Chief Innovation Officer and Board member.

"We are thrilled to partner with Jeff, Scott, Hans and their teams at Relevate and Arteric. The combined entity offers an exciting new platform for Mountaingate that we believe will see exceptional growth and success," said Bruce Rogers, Managing Director of Mountaingate Capital.